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DOI 10.1016/j.stem.2007.03.001Human embryonic stem cells (hES
cells) were first derived in 1998 and
hold great promise for opening up
new avenues in regenerative medicine
through the generation of transplant-
able cells to be used in future cell re-
placement therapies (Menendez et al.,
2006; Reubinoff et al., 2000; Thomson
et al., 1998). However, there is exten-
sive discussion about ethical aspects
of the use of human embryos for stem
cell research (Edwards, 2005; ESHRE
Taskforce on Ethics and Law, 2001,
2002; McLaren, 2001). Part of this dis-
cussion relates to intense public de-
bate about the ethics and implications
of in vitro fertilization (IVF) and its
associated procedures (Edwards and
Beard, 1997). In IVF treatment cycles,
the number of embryos generated
usually exceeds the number that can
be prudently transferred to the future
mother, and these surplus embryos
can potentially be used for stem cell
research. The 2003 SART-RAND study
estimated that at that time there were
400,000 stored embryos in 430 US
IVF clinics (Hoffman et al., 2003; Kaiser
Network, 2007). In Spain, the estimate
is that in 2003 there were 100,000
stored embryos in 203 Spanish IVF
clinics. In other countries, the specific
legislative environment influences both
the numbers of stored embryos and
their potential availability for dona-
tion for stem cell research (see, for
example, Koeferl Puorger et al. [2006]).
Despite being a very Catholic coun-
try, Spain currently represents a fairly
permissive legal and ethical environ-
ment for the use of excess embryos
for hES cell research. Although IVF cy-
cles must not be planned specificallyfor the generation of human embryos
to be used for stem cell research, cry-
opreserved embryos fewer than 14
days past fertilization may be used
for hES cell line derivation regardless
of the length of time that they have
been kept frozen. Moreover, the Span-
ish government recently passed a bill
to permit therapeutic cloning and cel-
lular reprogramming. The only require-
ment for hES cell line derivation and
use is that the procedures must be
linked to a specific research project.
Many countries, including Spain and
the UK, have set up stem cell banks
to provide researchers with hES cell
lines and facilitiate hES cell research.
Although UK and Swedish legislation
allow the use of fresh embryos, most
countries only permit donation of
spare cryopreserved embryos for bio-
medical research. Importantly, while
embryos are becoming more accessi-
ble for physicians and embryologists
who work within IVF units, access to
embryos for basic researchers in
stem cell centers and academic insti-
tutions not directly linked to an IVF
clinic remains a major challenge.
Stem cell banks such as ours need
to derive new hES cell lines for both in-
ternational distribution and for our own
hES cell research projects. To investi-
gate the interest of Spanish couples
in donating supernumerary cryopre-
served embryos for hES cell research,
we have conducted interviews with
97 couples covering two IVF units.
We conducted an extensive analysis
through personal interviews in which
couples were asked to make a decision
about the fate of embryos cryopre-
served for more than 3 years in publicCell StemIVF units not linked to the stem cell
bank. The interviews were carried out
by a senior embryologist and a legal
advisor and were supervised by the
head of the IVF clinic. The law in
many countries does not allow embryo
donation for the treatment of other in-
fertile couples (Bjuresten and Hovatta,
2003). Spanish law, however, like U.S.
legislation, does permit this alternative
(Hoffman et al., 2003). Thus, current
Spanish law obliged us to offer the
couples four options regarding the
fate of the surplus cryopreserved
embryos: (1) to keep the embryos cry-
opreserved for potential future repro-
ductive purposes, (2) to donate em-
bryos to other infertile couples for
reproductive purposes, (3) to donate
the embryos to biomedical research
(including stem cell research), or (4)
to discard the embryos. The four pos-
sible embryo fates were explained in
detail to all the couples by the senior
embryologist in an unbiased manner
(Cortes et al., 2006). The interview in-
cluded a brief summary of the couple’s
IVF cycle, covering the oocyte acquisi-
tion date, the number of embryos ob-
tained, the number of embryos frozen,
and the number of births. The legal sit-
uation and potential concerns of the
couples about donation for biomedical
research were addressed by the legal
advisor and the senior embryologist.
When the first option (to keep embryos
cryopreserved for potential future re-
productive purposes) was explained
to the couples, it was made clear that
the embryos could be frozen until the
end of the fertility age of the woman,
which would be assessed by a
gynecologist. For the second optionCell 1, July 2007 ª2007 Elsevier Inc. 17
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CorrespondenceFigure 1. Summary of the Choices Made by Interviewed Couples about the Fate of Supernumerary Cryopreserved Human
Embryos
Couples from two different Public IVF Public Units (HUVR and HUVN) were interviewed about the potential fate of their spare embryos that had been
frozen for more than 3 years. In accordance with Spanish legislation, the couples were offered four options: (A) to keep the embryos cryopreserved for
potential future reproductive purposes, (B) to donate embryos to other infertile couples for reproductive purposes, (C) to donate embryos to biomed-
ical research (including stem cell research), or (D) to discard surplus embryos. The four possible embryo fates were explained in detail to all the
couples by the senior embryologist and a legal advisor in an unbiased manner. HUVN, Virgen de las Nieves Hospital, Granada, Spain; HUVR, Virgen
del Rocio Hospital, Seville, Spain; n, number of couples with embryos cryopreserved for more than 4 years. (E) Number of cryopreserved human
embryos. *P value, (A) versus (B), p < 0.00001; (B) versus (C), p < 0.00001.(donation of embryos to other infertile
couples), it was made clear that this
donation would be for reproductive
ends and require renunciation of any
resulting pregnancy. With respect to
the third option (donation of embryos
to research), the couples received
up-to-date information about research
projects being carried out in the field of
stem cell research, including the deri-
vation of hES cell lines and their possi-
ble future application in regenerative
medicine and cell therapy, develop-
mental biology, drug screening, dis-
ease modeling, and other areas. One
stem cell research project was also ex-
plained in detail to accommodate the
Spanish legal requirement that the do-
nation of embryos must be related to
a specific research project. Following
the interview, couples were then asked
to read, understand, and sign an in-
formed consent form that, according
to the Spanish law, was anonymous,
confidential, voluntary, altruistic, and
revocable. The legal advisor was pres-
ent at all times to ensure that the inter-18 Cell Stem Cell 1, July 2007 ª2007 Elsview was unbiased and allowed the
couples to go through the decision-
making process independently.
We found that 49% of the inter-
viewed couples chose to donate their
embryos for stem cell research, and
44% decided to keep them cryopre-
served. Only 7% chose to donate
them to other infertile couples, and
less than 1% made the decision to dis-
card them (Figure 1). Importantly, sim-
ilar results were obtained from couples
who underwent IVF cycles in IVF units
in two cities with different social and
economic profiles (Figure 1). These re-
sults differ from a recent report from
a clinic in the U.S., which indicated
that 54% of treated couples asked to
have their embryos destroyed, 43%
decided to donate them to biomedical
research unrelated to stem cells (al-
though donation for stem cell research
was not discussed), and 3% offered
them to other infertile couples (Kaiser
Network, 2007). Furthermore, the more
extensive SART-RAND study carried
out in the U.S. in 2003 (Hoffman et al.,evier Inc.2003) found that only 2.8% of cryopre-
served embryos were designated for
stem cell research, which obviously
limits possible conversion into hES
cell lines (Hoffman et al., 2003).
It is worth emphasizing that, in our
study, half of the interviewed couples
opted to donate their surplus stored
embryos for stem cell research. Al-
though it should be stressed that the
aims and execution of the two studies
were clearly very different, our find-
ings do contrast sharply with those de-
scribed in the SART-RAND study pub-
lished in 2003. In our view, there are
a number of potential reasons for the
differences, and we have outlined
our perspective on the most significant
of these in a summary table (Table 1).
We consider the differences are likely
due to the following. (1) the SART-
RAND study’s major aim being to
determine, using a questionnaire, the
number of embryos stored in IVF
clinics and the number of embryos tar-
geted for stem cell research. By con-
trast, we already knew in advance the
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CorrespondenceTable 1. Potential Reasons for the Differences in the Outcome of Embryo Donation for Stem Cell Research between
Our Study and the Previously Published SART-RAND Study
Possible Reasons for the
Differences between Studies Hoffman et al. (2003) Present Study
Percent of embryos donated
to stem cell research
2.8% 45%
Aims of the study (1) To determine the number of
embryos stored in US IVF clinics
(1) To determine the percentage of
couples willing to donate their embryos
for stem cell research based on a
cohort of patients with embryos frozen
for more than 3 years and knowing in
advance the pregnancy success rate
(2) To determine prospectively the
percentage of couples willing to
donate their embryos for
stem cell research
Type of communication between
the IVF clinic and queried couples
Questionnaire sent to the couples Personal interview
Strategy to reduce confusion about
ethical and research issues
Not evaluated Presence during the interview
process of a senior embryologist
and head of the IVF clinic
Time of contact with the couples Before or shortly after the IVF cycles 3–4 years after embryo
cryopreservation with known
pregnancy success rates
approaching 40%number of embryos frozen for more
than 3 years and the pregnancy suc-
cess rate, facilitating the interview pro-
cess. (2) The SART-RAND study was
conducted by sending a questionnaire
to clinics but did not involve an inter-
view. We instead undertook a time-
consuming process in which we con-
ducted formal interviews with all the
couples as described above. We found
that the interview process allowed us
to address the couples’ concerns
about ethical and scientific questions.
The interviews were conducted in an
unbiased manner, but this level of per-
sonal attention could be a persuasive
factor in terms of donation to research.
(3) The SART-RAND survey included
couples at many different stages of
the IVF process, including before or
just after the cycle, so it is likely that,
in this scenario, most couples of repro-
ductive age would choose to keep their
embryos cryopreserved for potential
future use. In our study, however, 97
couples with embryos frozen for more
than 3 years were interviewed. At this
stage, slightly more than 35% of cou-
ples had babies, and in fact nearly
30% of them had twins, while only
a few had triplets. Clearly, such cir-cumstances make the decision to do-
nate surplus embryos for research
more appealing. In fact, we suspect
that if a similar survey using an inter-
view process were carried out at this
time with U.S. couples who have em-
bryos preserved for 3 years or more,
the outcome would be closer to our re-
sults than the earlier SART-RAND find-
ings. The likelihood of such an out-
come would be even greater if hES
cell derivation was supported by U.S.
government funding. Furthermore, al-
though donation of fresh embryos is
prohibited in many countries, a study
carried out in a Sweden, where this
process is permitted, found that
a very high proportion (92%) of queried
couples chose to donate embryos that
were not of sufficient quality for implan-
tation or cryopreservation for research
purposes, including stem cell research,
rather than to have them destroyed
(Bjuresten and Hovatta, 2003). Thus, if
the legislative conditions change, it is
possible that discarded fresh embryos
could alsobea significantsourceofma-
terial for research.
To conclude, we have found that a
personal interview with a senior em-
bryologist and a legal advisor is pro-Cell Stemductive in ascertaining the willingness
of couples to donate embryos for
stem cell research. The interview pro-
cess helps couples navigate the con-
fusing legal situation and can be used
to alleviate any concerns they have
about donation for research purposes.
We hope that our findings will promote
new initiatives among other stem cell
researchers and experts in ethics and
stem cell counseling to facilitiate prog-
ress in hES cell research.
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